Yanming Chen
1055 Sanxiang Rd
Suzhou, 215004, China
Suzhou, 215004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Design and Synthesis of a Novel Covalent Dihydropteridinone Derivative as a Highly Potent and Orally Bioavailable PLK1 Inhibitor for the Treatment of Chronic Myeloid Leukemia.
Journal: Journal of medicinal chemistry
Published: June 30, 2026
Intracellular gelation of biomaterials: strategies, characterization, and biomedical applications.
Journal: Materials horizons
Published: May 22, 2026
AIS-based spatiotemporal carbon emission reduction potential of coastal shipping in China.
Journal: Journal of environmental management
Published: May 10, 2026
Pure 3D-endoscopic removal of supra-infratentorial tumor via Paramedian Supracerebellar Infratentorial Transtentorial (SCITTT) keyhole approach.
Journal: Acta neurochirurgica
Published: April 27, 2026
TIGAR Maintains Mitotic Spindle Organization and βII-Tubulin Stability in Glioma Stem Cells.
Journal: CNS neuroscience & therapeutics
Published: March 22, 2026
1,2-propanediol reformulation improves tribromoethanol safety and reveals pontine GABRA1 enrichment as a candidate mechanistic correlate of anesthesia.
Journal: Animal models and experimental medicine
Published: February 02, 2026
A multimodal prediction model for brain hematoma expansion based on deep neural network with transformer-driven collaborative attention fusion.
Journal: Medical & biological engineering & computing
Published: January 28, 2026
A Nanoparticle-Integrated Complete Manufacturing Pipeline of Chemically Engineered Exosomes.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 03, 2025
Attention re-alignment in multimodal large language models via intermediate-layer guidance.
Journal: Scientific reports
Published: October 27, 2025
Case Report: FGFR1 mutation and massive chromosome loss drive malignant transformation of low-grade gliomas.
Journal: Frontiers in oncology
Published: August 29, 2025
Structure-Based Discovery of Quinazolin-2-amine Derivatives as Potent ROR1 Pseudokinase Inhibitors with In Vitro and In Vivo Efficacy against Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: July 30, 2025
Last Updated: 09/26/2026